| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 400.43B | 393.31B | 307.55B | 284.13B | 253.78B | 182.86B |
| Gross Profit | 281.02B | 277.45B | 208.60B | 184.47B | 153.97B | 106.83B |
| EBITDA | 178.39B | 180.34B | 125.61B | 123.16B | 100.80B | 60.25B |
| Net Income | 123.94B | 123.89B | 84.21B | 82.89B | 66.21B | 39.09B |
Balance Sheet | ||||||
| Total Assets | 620.08B | 654.09B | 560.42B | 472.69B | 404.54B | 329.03B |
| Cash, Cash Equivalents and Short-Term Investments | 198.50B | 229.17B | 215.49B | 163.05B | 125.77B | 109.81B |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities | 135.16B | 161.38B | 153.85B | 124.65B | 110.73B | 76.67B |
| Stockholders Equity | 484.62B | 492.36B | 406.37B | 347.80B | 293.54B | 252.14B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 52.41B | 81.31B | 67.58B | 40.08B | 35.68B |
| Operating Cash Flow | 0.00 | 120.36B | 97.52B | 81.78B | 83.65B | 56.71B |
| Investing Cash Flow | 0.00 | -68.00B | -16.40B | -13.08B | -43.59B | -13.11B |
| Financing Cash Flow | 0.00 | -38.15B | -30.94B | -32.09B | -27.19B | -15.82B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥2.87T | 25.03 | 53.12% | 1.11% | 32.51% | 57.19% | |
79 Outperform | ¥17.93T | 33.18 | 26.01% | 1.79% | 16.74% | 16.03% | |
78 Outperform | ¥1.75T | 15.60 | 21.73% | 2.29% | 11.29% | 11.38% | |
77 Outperform | €581.00B | 24.84 | 12.66% | 2.28% | 9.53% | -11.17% | |
75 Outperform | ¥7.08T | 35.55 | 25.78% | 0.79% | 13.45% | 20.37% | |
62 Neutral | ¥1.26T | 44.15 | ― | 0.73% | 10.98% | 6.51% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% |